These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 17683946)
1. Inhibitory costimulation and anti-tumor immunity. Martin-Orozco N; Dong C Semin Cancer Biol; 2007 Aug; 17(4):288-98. PubMed ID: 17683946 [TBL] [Abstract][Full Text] [Related]
2. Regulation of costimulation in the era of butyrophilins. Arnett HA; Escobar SS; Viney JL Cytokine; 2009 Jun; 46(3):370-5. PubMed ID: 19380239 [TBL] [Abstract][Full Text] [Related]
3. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824 [TBL] [Abstract][Full Text] [Related]
4. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation. Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399 [TBL] [Abstract][Full Text] [Related]
5. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules. Mauri D; Wyss-Coray T; Gallati H; Pichler WJ J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409 [TBL] [Abstract][Full Text] [Related]
6. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Salomon B; Bluestone JA Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036 [TBL] [Abstract][Full Text] [Related]
7. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. Sigal LJ; Reiser H; Rock KL J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331 [TBL] [Abstract][Full Text] [Related]
8. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. Racke MK; Scott DE; Quigley L; Gray GS; Abe R; June CH; Perrin PJ J Clin Invest; 1995 Nov; 96(5):2195-203. PubMed ID: 7593605 [TBL] [Abstract][Full Text] [Related]
9. Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules. Moro M; Gasparri AM; Pagano S; Bellone M; Tornaghi P; Veglia F; Corti A; Casorati G; Dellabona P Cancer Res; 1999 Jun; 59(11):2650-6. PubMed ID: 10363988 [TBL] [Abstract][Full Text] [Related]
10. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. van Rijt LS; Vos N; Willart M; Kleinjan A; Coyle AJ; Hoogsteden HC; Lambrecht BN J Allergy Clin Immunol; 2004 Jul; 114(1):166-73. PubMed ID: 15241361 [TBL] [Abstract][Full Text] [Related]
11. A more selective costimulatory blockade of the CD28-B7 pathway. Poirier N; Blancho G; Vanhove B Transpl Int; 2011 Jan; 24(1):2-11. PubMed ID: 20964725 [TBL] [Abstract][Full Text] [Related]
12. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170 [TBL] [Abstract][Full Text] [Related]
13. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2. Biburger M; Weth R; Wels WS J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482 [TBL] [Abstract][Full Text] [Related]
14. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. Tao X; Constant S; Jorritsma P; Bottomly K J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393 [TBL] [Abstract][Full Text] [Related]
15. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772 [TBL] [Abstract][Full Text] [Related]
16. The B7 family revisited. Greenwald RJ; Freeman GJ; Sharpe AH Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580 [TBL] [Abstract][Full Text] [Related]
17. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis. Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755 [TBL] [Abstract][Full Text] [Related]
18. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. Guerder S; Carding SR; Flavell RA J Immunol; 1995 Dec; 155(11):5167-74. PubMed ID: 7594526 [TBL] [Abstract][Full Text] [Related]
19. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397 [TBL] [Abstract][Full Text] [Related]
20. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity. Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]